Why the study?
The authors aimed to derive a new hs-cTnI-Access 0/1h algorithm suitable for Chinese patients with suspected NSTEMI.
Does an adjusted hs-cTnI-Access 0/1h-algorithm improve the diagnostic accuracy and safety of ruling out NSTEMI in Chinese patients compared to the standard ESC 0/1h-algorithm?
Does an adjusted hs-cTnI-Access 0/1h-algorithm improve the diagnostic accuracy and safety of ruling out NSTEMI in Chinese patients compared to the standard ESC 0/1h-algorithm?
Answers are grounded in this paper and cite their sources.
Adjusting the cut-off values of the high-sensitivity cardiac troponin I 0/1h algorithm specifically for Chinese patients achieved the required >99% negative predictive value, overcoming the shortcomings of the European Society of Cardiology cut-offs in this population.
We aimed to derive a new high-sensitivity cardiac troponin I Access (hs-cTnI-Access) 0/1h-algorithm suitable for Chinese patients. In the multi-centre study, we enrolled 369 patients with suspected non-ST-segment elevation myocardial infarction (NSTEMI). Following an adjustment, AnZhen hs-cTnI-Access 0/1h-algorithm was established with rule-in cut-off values of 0 h ≥ 50 pg/mL or Δ1h ≥ 18.0 pg/mL and rule-out cut-off values of 0 h < 3 pg/mL or 0 h < 4 pg/mL and Δ1h < 3.0 pg/mL. These revised cutoffs presented a negative predictive value (NPV) of 99.46% (95% CI,97.02-99.91%) and a sensitivity of 98.81% (95% CI,93.56-99.79%), and also resulted in a positive predictive value (PPV) of 86.42% (95% CI,77.30-92.24%) and a specificity of 96.14% (95% CI,93.22-97.83%), both of which were superior to those of the ESC 0/1 h algorithm. The new hs-cTnI-Access 0/1 h-algorithm adjusted for Chinese data is promising for improving both safety and efficacy in Chinese patients.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: